Drawing for IQ TESTED INGREDIENT QUALITY ACTIVE COMPOUNDS

USPTO serial 75517583

IQ TESTED INGREDIENT QUALITY ACTIVE COMPOUNDS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BHATTI, FARAH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IQ TESTED INGREDIENT QUALITY ACTIVE COMPOUNDS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LESTER K ESSIG

LESTER K ESSIG RAY QUINNEY & NEBEKERP O BOX 45385SALT LAKE CITY, UT 84145-0385UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005dietary supplements, and herbs, botanicals, extracts, concentrates, constituents and combinations for use as dietary supplements; and medications, namely substances and preparations for use in the treatment of allergies, hay fever, nasal congestion, asthma, shortness of breath, tightness of the chest, wheezing, stress, tension, common cold, fatigue, diarrhea, gas pains, abdominal cramps, stomach distress, intestinal distress, bloating, distension, fullness, pressure, water-weight gain, swelling, inflammation, fevers, irregularity, constipation, detoxification, gout, sleep disorders, depressive disorders, headaches, motion sickness, nausea, vomiting, low energy, dietary deficiencies, nutritional deficiencies, poor health, blood conditions, circulatory conditions, cardiac conditions, digestive conditions, urinary conditions, premenstrual conditions, menstrual conditions, menopausal and other female conditions, prostate and other male conditions, eye conditions, skin conditions, hair conditions, immune system conditions, metabolic conditions, conditions of the joints and conditions associated with agingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 11, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 19, 2000NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 27, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 26, 2000NPUBNOTICE OF PUBLICATION—
Dec 21, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 16, 1999CNEAEXAMINER'S AMENDMENT MAILED—
Dec 16, 1999ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 3, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 28, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 29, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance